|
Real-time Estimate
Cboe BZX
06:02:44 18/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 5.245 USD | +4.90% |
|
+1.43% | -48.20% |
| Market Cap | 183M 166M 153M 138M 261M 17.05B 271M 1.84B 730M 9.2B 685M 670M 29.08B | P/E 2026 * |
-1.25x | P/E 2027 * | -1.35x |
|---|---|---|---|---|---|
| Enterprise Value | 183M 166M 153M 138M 261M 17.05B 271M 1.84B 730M 9.2B 685M 670M 29.08B | EV / Sales 2026 * |
45.1x | EV / Sales 2027 * | 8.97x |
| Free-Float |
84.29% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TRDA | Delayed | |
| TRDA | Real-time |
Last Transcript: Entrada Therapeutics, Inc.
| 21/12/22 | Nipte winst op Wall Street | |
| 21/12/22 | Wall Street licht hoger | |
| 21/12/22 | Wall Street richting rode opening |
| 1 day | +4.90% | ||
| 1 week | +1.43% | ||
| Current month | +17.42% | ||
| 1 month | +10.48% | ||
| 3 months | -27.25% | ||
| 6 months | -9.59% | ||
| Current year | -48.20% |
| 1 week | 4.84 | 5.49 | |
| 1 month | 4.26 | 5.49 | |
| Current year | 4.11 | 16.45 | |
| 1 year | 4.11 | 16.45 | |
| 3 years | 4.11 | 21.79 | |
| 5 years | 4.11 | 36.85 | |
| 10 years | 4.11 | 36.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
CEO | Chief Executive Officer | 50 | 01/08/2017 |
Kory Wentworth
DFI | Director of Finance/CFO | 47 | 01/11/2020 |
Nathan Dowden
PSD | President | 56 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Dipal Doshi
BRD | Director/Board Member | 50 | 01/08/2017 |
Kush Parmar
CHM | Chairman | 45 | 01/12/2020 |
Peter Kim
BRD | Director/Board Member | 67 | 01/12/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/9/26 | MPM BioImpact LLC
| Sell | Company | -28,837 | 0.0741% | |
| 9/9/26 | MPM BioImpact LLC
| Sell | Company | -28,837 | 0.0741% | |
| 3/9/26 | MPM BioImpact LLC
| Sell | Company | -32,263 | 0.0829% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.90% | +1.43% | -37.13% | -67.17% | 183M | ||
| +1.15% | -2.81% | +53.73% | +71.00% | 65.56B | ||
| -2.64% | -1.13% | +7.82% | +88.90% | 60.41B | ||
| -1.07% | +0.30% | +22.91% | +86.76% | 55.76B | ||
| -0.41% | -3.31% | +8.85% | +119.37% | 46.98B | ||
| -2.20% | -5.35% | +20.50% | +27.16% | 43.63B | ||
| -0.70% | +1.43% | +14.05% | +45.20% | 36.7B | ||
| -2.06% | -15.09% | +137.08% | +668.50% | 36.09B | ||
| -0.77% | -2.21% | +77.27% | +57.96% | 32.9B | ||
| -1.17% | +2.03% | -38.24% | +391.18% | 26.96B | ||
| Average | -0.48% | -0.87% | +26.68% | +148.89% | 41B | |
| Weighted average by Cap. | -1.00% | -1.48% | +33.44% | +147.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.05M 3.67M 3.39M 3.06M 5.78M 378M 6M 40.9M 16.18M 204M 15.19M 14.87M 645M | 20.36M 18.48M 17.07M 15.4M 29.07M 1.9B 30.19M 206M 81.35M 1.03B 76.37M 74.76M 3.24B |
| Net income | -168M -153M -141M -127M -241M -15.74B -250M -1.7B -673M -8.49B -632M -619M -26.83B | -180M -163M -151M -136M -257M -16.78B -266M -1.82B -718M -9.06B -674M -660M -28.61B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/11/26 | USD 5.325 | +6.50% | 136,862 |
| 16/11/26 | USD 5.000 | -1.77% | 607,027 |
| 13/11/26 | USD 5.090 | -1.55% | 791,644 |
| 12/11/26 | USD 5.170 | -4.96% | 808,660 |
| 11/11/26 | USD 5.440 | +3.62% | 760,792 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- TRDA Stock
Select your edition
All financial news and data tailored to specific country editions
















